Merus N.V. logo
Merus N.V. MRUS

Quarterly report 2025-Q3
added 10-31-2025

report update icon

Merus N.V. P/S Ratio 2011-2026 | MRUS

Annual P/S Ratio Merus N.V.

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
82.5 57.1 20.4 19.4 26.9 K 13.1 7.67 24.3 234 - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
26.9 K 7.67 3.04 K

P/S Ratio of other stocks in the Biotechnology industry

Issuer P/S Ratio Price % 24h Market Cap Country
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
65.5 - - $ 26.5 M usaUSA
MorphoSys AG MorphoSys AG
MOR
1.75 - 2.43 % $ 254 M germanyGermany
Advaxis Advaxis
ADXS
144 - -9.65 % $ 45.9 M usaUSA
I-Mab I-Mab
IMAB
94.1 - - $ 866 M chinaChina
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
489 - - $ 1.01 B usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
131 $ 4.55 -0.66 % $ 10.9 B australiaAustralia
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
106 - -11.43 % $ 502 K usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
137 - -18.52 % $ 27.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.53 - - $ 40.3 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
105 $ 0.91 3.25 % $ 6.69 M chinaChina
Compugen Ltd. Compugen Ltd.
CGEN
49.8 $ 2.59 -5.13 % $ 242 M israelIsrael
Genfit SA Genfit SA
GNFT
1.96 K - 2.54 % $ 160 B franceFrance
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
3.33 $ 22.53 -0.62 % $ 3.73 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.39 K - -1.52 % $ 24.7 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
0.935 - 1.93 % $ 17.4 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
54.1 - - $ 8.42 M usaUSA
Aptinyx Aptinyx
APTX
204 - -39.0 % $ 4.57 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
2.61 - - - russiaRussia
Aeterna Zentaris Aeterna Zentaris
AEZS
7.87 - 5.93 % $ 314 M canadaCanada
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
11.2 - - $ 7.46 M israelIsrael
AgeX Therapeutics AgeX Therapeutics
AGE
0.099 - -10.17 % $ 12.2 K usaUSA
Aravive Aravive
ARAV
6.61 - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
1.34 - 17.91 % $ 11.1 M usaUSA
BioNTech SE BioNTech SE
BNTX
35.7 $ 100.76 -1.27 % $ 27.2 B germanyGermany
BioDelivery Sciences International BioDelivery Sciences International
BDSI
1.85 - -4.8 % $ 255 M usaUSA
Inventiva S.A. Inventiva S.A.
IVA
128 $ 4.94 -1.4 % $ 138 M franceFrance
Aquestive Therapeutics Aquestive Therapeutics
AQST
10.5 $ 4.06 -0.86 % $ 434 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
9.15 $ 22.64 -2.81 % $ 2.88 B usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.27 $ 1.42 -4.39 % $ 378 M britainBritain
AstraZeneca PLC AstraZeneca PLC
AZN
2.17 - - $ 96.9 B britainBritain
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
759 $ 2.97 2.06 % $ 4.89 M israelIsrael
BeiGene, Ltd. BeiGene, Ltd.
BGNE
66.4 - 0.49 % $ 251 B cayman-islandsCayman-islands
CureVac N.V. CureVac N.V.
CVAC
281 - - $ 867 M germanyGermany
bluebird bio bluebird bio
BLUE
2.27 - - $ 546 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
2.58 - -3.03 % $ 260 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
36.1 - - $ 35.4 M usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
24 $ 1.03 -2.83 % $ 12.6 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
0.0564 - - $ 3.74 B usaUSA
Cabaletta Bio Cabaletta Bio
CABA
50.3 M $ 2.79 -2.62 % $ 280 M usaUSA